Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
September 19, 2022
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease
Douglas M Watts, Jonna L B Westover, Pedro M Palermo, et al.
Journal of Virology
|
March 20, 2024
Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC
Jack H Nunberg, Jonna B Westover, Joanne York, et al.
ACS Medicinal Chemistry Letters
|
April 20, 2023
An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the <i>Bunyavirales</i> Order
Kevin J Sparrow, Rinu Shrestha, James M Wood, et al.
Virology
|
September 3, 2017
Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir
Jonna B Westover, Johanna D Rigas, Arnaud J Van Wettere, et al.
Nature Communications
|
September 13, 2023
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
Nathaniel S Chapman, Ruben J G Hulswit, Jonna L B Westover, et al.
Research Square
|
April 10, 2026
A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection
Samantha R Wasson, Yanan Liu, Minghao Li, et al.
Plos Pathogens
|
February 17, 2026
Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain
Guido C Paesen, Nathaniel S Chapman, Jonna B Westover, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2021
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition
Nathaniel S Chapman, Haiyan Zhao, Nurgun Kose, et al.
Antiviral Research
|
July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023
Jessica R Spengler, Kara Carter, Leen Delang, et al.
Plos Pathogens
|
December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinant
Ikenna G Madu, Megan Files, Dima N Gharaibeh, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
The American Journal of Tropical Medicine and Hygiene
|
September 19, 2022
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease
Douglas M Watts, Jonna L B Westover, Pedro M Palermo, et al.
Journal of Virology
|
March 20, 2024
Restoration of virulence in the attenuated Candid#1 vaccine virus requires reversion at both positions 168 and 427 in the envelope glycoprotein GPC
Jack H Nunberg, Jonna B Westover, Joanne York, et al.
ACS Medicinal Chemistry Letters
|
April 20, 2023
An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the <i>Bunyavirales</i> Order
Kevin J Sparrow, Rinu Shrestha, James M Wood, et al.
Virology
|
September 3, 2017
Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir
Jonna B Westover, Johanna D Rigas, Arnaud J Van Wettere, et al.
Nature Communications
|
September 13, 2023
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
Nathaniel S Chapman, Ruben J G Hulswit, Jonna L B Westover, et al.
Research Square
|
April 10, 2026
A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection
Samantha R Wasson, Yanan Liu, Minghao Li, et al.
Plos Pathogens
|
February 17, 2026
Structural basis for recognition of Rift Valley fever virus Gn protein by a human neutralizing monoclonal antibody with a kappa light chain
Guido C Paesen, Nathaniel S Chapman, Jonna B Westover, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 30, 2021
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition
Nathaniel S Chapman, Haiyan Zhao, Nurgun Kose, et al.
Antiviral Research
|
July 26, 2023
Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023
Jessica R Spengler, Kara Carter, Leen Delang, et al.
Plos Pathogens
|
December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinant
Ikenna G Madu, Megan Files, Dima N Gharaibeh, et al.
Page
of 12